Reagan Kelly

A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure

Stephen B. Liggett, Sharon Cresci, Reagan Kelly et al. · Nature Medicine · 2008 · 321 citations · Full text

Medicine, Cardiology, Pharmacology +16

Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay individuals.

Reagan Kelly, Robert D. Larsen, J G Bryant et al. · Proceedings of the National Academy of Sciences · 1994 · 192 citations · Full text

Life Sciences, Biochemistry, Genetics +11

Quantitative Structure-Activity Relationship Models for Predicting Drug-Induced Liver Injury Based on FDA-Approved Drug Labeling Annotation and Using a Large Collection of Drugs

Minjun Chen, Huixiao Hong, Hong Fang et al. · Toxicological Sciences · 2013 · 118 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Clinical and Genetic Modifiers of Long-Term Survival in Heart Failure

Sharon Cresci, Reagan Kelly, Thomas P. Cappola et al. · Journal of the American College of Cardiology · 2009 · 115 citations · Full text

Medicine, Cardiology, Genetics +16

Translating Clinical Findings into Knowledge in Drug Safety Evaluation - Drug Induced Liver Injury Prediction System (DILIps)

Zhichao Liu, Qiang Shi, Don Ding et al. · PLoS Computational Biology · 2011 · 99 citations · Full text

Pharmacy, Pharmacology, Toxicology +17